MAP1LC3B and glioblastoma: Recently, some reports have documented hyper-activation of CMA in GBM through the expression of LC3B, LAMP1, and LAMP2A, with their downregulation due to curcumin [24,25,26]; however, the real implication of CMA-mediated degradation in GBM is still debated.